chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Feeling abnormal, Myalgia
Clinical narrative: immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, after 12 hours of vaccination at 23:00, the patient experienced shortness of breath, brief fever, chills, muscle soreness, head fog and exhaustion. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were provided for the reported events. The clinical outcome of the events shortness of breath, brief fever, chills, muscle soreness, head fog and exhaustion were resolved with lasting effects at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, after 12 hours of vaccination at 23:00, the patient experienced shortness of breath, brief fever, chills, muscle soreness, head fog and exhaustion. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were provided for the reported events. The clinical outcome of the events shortness of breath, brief fever, chills, muscle soreness, head fog and exhaustion were resolved with lasting effects at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site pain
Clinical narrative: soreness at injection site and in armpit.; soreness in armpit of the same arm as injection site; This is a spontaneous report from a contactable consumer. A 63-years-old adult non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732), via unspecified route of administration on 20Mar2021 at 14:15, (at the age of 63 years) as a single dose for COVID-19 immunisation on left arm. Medical history was not reported. Concomitant medications were not reported. The patient also received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205), via unspecified route of administration on left arm on 04Mar2021, (at the age of 63 years) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. On 26Mar2021 the patient experienced soreness at injection site and in armpit of the same arm as injection site. The patient did not receive any treatment for adverse event soreness at injection site and arm pit of the same arm as injection site. The clinical outcome of the event soreness at injection site and arm pit was recovering.   No follow-up attempts possible. No further information expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Vaccination site pain
Clinical narrative: Chills; slightly sore at injection site; nausea; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 25Mar2021 at 10:00 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take receive any other medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 20:00, the patient experienced chills, slightly sore at injection site and nausea. No therapeutic measures were taken as a result of the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the events chills, vaccination site pain and nausea were unknown at the time of this report.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: Pain at injection site; High fever; Body shaking; Headache; Chills; Sweats; Felt very nauseated like a had a hang-over for a week.; Blistery rash on my back; This is a spontaneous report received from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: FL9266), via an unspecified route of administration in the left arm on 13Feb2021 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included blood pressure medication, thyroid medication and estrogen (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL9262), via an unspecified route of administration in the left arm on 23Jan2021 at 09:30 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 13Feb2021 at 20:00 (after 13 hours of second vaccination), the patient experienced pain at injection site, high fever, body was shaking, headache, chills and sweats which existed for 14 hours. On an unspecified date in 2021, the patient felt nauseated like a hangover for a week. The patient also had a blistery rash on her back that was scabbing over at the time of this report. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pain at injection site, high fever, body shaking, headache, chills, sweats were recovered on 14Mar2021; nauseated was recovered on an unspecified date and blistery rash was not recovered at the time of this report.  No follow-up attempts possible. No further information expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash vesicular, Tremor, Vaccination site pain
Clinical narrative: Pain at injection site; High fever; Body shaking; Headache; Chills; Sweats; Felt very nauseated like a had a hang-over for a week.; Blistery rash on my back; This is a spontaneous report received from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: FL9266), via an unspecified route of administration in the left arm on 13Feb2021 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included blood pressure medication, thyroid medication and estrogen (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL9262), via an unspecified route of administration in the left arm on 23Jan2021 at 09:30 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 13Feb2021 at 20:00 (after 13 hours of second vaccination), the patient experienced pain at injection site, high fever, body was shaking, headache, chills and sweats which existed for 14 hours. On an unspecified date in 2021, the patient felt nauseated like a hangover for a week. The patient also had a blistery rash on her back that was scabbing over at the time of this report. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pain at injection site, high fever, body shaking, headache, chills, sweats were recovered on 14Mar2021; nauseated was recovered on an unspecified date and blistery rash was not recovered at the time of this report.  No follow-up attempts possible. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue
Clinical narrative: Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via unspecified route of administration in the arm left on 26Mar2021 at 11:15 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via unspecified route of administration in the left arm on 04Mar2021 at 10:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 27Mar2021 at 03:00, the patient experienced diarrhea and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcome of the events diarrhea and fatigue was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Headache
Clinical narrative: Exhausted/tired; Headaches; Have not been able to get warm; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25Mar2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included fertilization issues. The patient did not have any known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for fertility reasons but not diabetic, topiramate (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), lisdexamfetamine mesilate (VYVANSE) and omeprazole (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021, the patient was not able to get warm. On 27Mar2021, the patient had headaches and from 28Mar2021, the patient felt exhausted and did not remember being so tired for so many days in a row after the vaccination. Therapeutic measures taken included treatment with alternated TYLENOL and ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events exhausted, not able to get warm and headaches were recovered with sequelae on an unknown date.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Joint swelling
Clinical narrative: Knee is so swollen that he cannot stand up/walk; knee is so swollen that he cannot stand up/walk; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown); via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 19:30, the patient experienced swollen knee that she cannot stand up/walk. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the knee swelling and walking difficulty was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Pain
Clinical narrative: Fatigue; joint pain; aches; headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via an unspecified route of administration on the left arm on 24Mar2021 at 13:15 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not allergic to medications, food, or other products. Concomitant medications included duloxetine hydrochloride(CYMBALTA) and  sertraline hydrochloride(ZOLOFT) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 11:30, patient experienced fatigue, joint pain, aches and headache. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, joint pain, aches and headache was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Vision blurred
Clinical narrative: very bad neck cramps; gave headache; blurry vision now; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: box-18) via an unspecified route of administration in the arm left on 29Mar2021 at 09:00  (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have allergies to medications, food, or other products. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and fluticasone propionate(FLONASE) on unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was reported as unknown if the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 01:00 PM the patient experienced very bad neck cramps, had headache and blurry vision. It was unknown if the patient took any treatment for the reported adverse events. The event resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the events was unknown at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Myalgia, Pyrexia, Vomiting
Clinical narrative: Chills; Fever; Repeated vomiting; Muscle aches; Felt bad since taking shot; This is a spontaneous report from a contactable consumer. A 71-year-old male patient received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 08:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included brain tumor operation and colectomy. The patient did not take any concomitant medications. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021, the patient experienced chills, fever, muscle ache, fever, repeated vomiting and felt bad after vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received unknown treatment for the reported events. The clinical outcome of chills, fever, muscle ache, fever, repeated vomiting and feeling bad were not recovered.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node under left arm; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 26Mar2021 at 11:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. The patient had no allergies to medications, food, or other product. Concomitant medication included unspecified medications within two weeks of vaccination for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 31Mar2021 at 05:00, five days after the vaccination, the patient experienced swollen lymph node under left arm, the arm that got the shot in. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node under left arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Feeling abnormal, Headache, Heart rate
Clinical narrative: Brain fog; Elevated heart rate; body pain; Lethargy; Headache; Body pain esp in joints; High temperature of 101.4 (typical was 97.7); This is a spontaneous report from a contactable consumer, the patient. A 49-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in left arm on 24Mar2021 at 16:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient had no known allergies. Concomitant medications included Multivitamin (MANUFACTURER UNKNOWN) and Melatonin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in left arm on 03Mar2021 at 18:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 05:45, the patient experienced experienced elevated heart rate and noticed it would not decrease with rest/laying down and was able to track with a Garmin device. It ranged from a low of 90 to a high of 136, typical resting HR is 65-75. Brain fog was what would consider very high, typically, the patient process info quickly, felt like could feel brain trying to work. The patient also experienced high temperature of 101.4 (typical was 97.7), headache, body pain especially in joints, lethargy.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event lethargy, high temperature, headache, body pain, joint pain and elevated heart rate and brain fog was resolved on an unknown date in Mar2021.    No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Lethargy, Pain, Pyrexia
Clinical narrative: Brain fog; Elevated heart rate; body pain; Lethargy; Headache; Body pain esp in joints; High temperature of 101.4 (typical was 97.7); This is a spontaneous report from a contactable consumer, the patient. A 49-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in left arm on 24Mar2021 at 16:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient had no known allergies. Concomitant medications included Multivitamin (MANUFACTURER UNKNOWN) and Melatonin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in left arm on 03Mar2021 at 18:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 05:45, the patient experienced experienced elevated heart rate and noticed it would not decrease with rest/laying down and was able to track with a Garmin device. It ranged from a low of 90 to a high of 136, typical resting HR is 65-75. Brain fog was what would consider very high, typically, the patient process info quickly, felt like could feel brain trying to work. The patient also experienced high temperature of 101.4 (typical was 97.7), headache, body pain especially in joints, lethargy.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event lethargy, high temperature, headache, body pain, joint pain and elevated heart rate and brain fog was resolved on an unknown date in Mar2021.    No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headaches for 2 days; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 10:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included escitalopram oxalate (LEXAPRO) and galcanezumab (EMGALITY); both for unknown indication since an unknown date. The patient did not received any other vaccines within 4 weeks prior to the  COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 06:00, the patient experienced headaches for two days and fatigue. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache was resolved on 01Apr2021, while that of the event fatigue was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Soreness of arm; Stiff muscles in movement of arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EAU), via an unspecified route of administration in the left arm on 30Mar2021 at 10:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, compromised immune system due to chemotherapy, high blood pressure (HBP), irregular heart rate, chondromalacia of both legs, chronic depression and bipolar. The patient previously received morphine and experienced a drug allergy.  Prior to the vaccination, the patient had undergone a COVID-19 test twice, on an unspecified date in the year 2020 and another test was on 01Sep2020; she tested negative both the times. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 17:30, the patient experienced soreness in arm, very stiff muscles in movement of arm. On the same day, the patient had brief headache that did not last. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date in Mar2021, after the vaccination, the patient underwent a COVID-19 test (nasal swab), and tested negative.  No therapeutic measures were taken for any of the reported events. The clinical outcome of the events soreness in arm, stiff muscle in movement of arm were resolving at the time of this report. The clinical outcome of the event headache was resolved on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Feeling abnormal, Heart rate, Heart rate increased, Hypertension
Clinical narrative: rapid HBR of 125 BPM; blood pressure of 145/82; Very uncomfortable; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm right on 26Mar2021 at 12:00(at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included estradiol (ESTROGEN) and progesterone (MANUFACTURER UNKNOWN) for unknown indication and start date. Patient did not have any allergies to food, medications and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 13:00 the patient experienced rapid HBR of 125 BPM and blood pressure of 145/82. It was very uncomfortable and started afternoon the day after and continued until early Sunday a.m. On an unknown date, the patient underwent HBR and the result was 125 BPM. On an unknown date, the patient underwent blood pressure and the result was 145/82 (unknown unit). The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rapid HBR of 125 BPM, blood pressure of 145/82 and feeling abnormal were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Epicondylitis
Clinical narrative: Joint pain; Tennis elbow; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL6199), via an unspecified route of administration in the right arm on 04Mar2021 at 17:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 10Feb2021 at 17:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021, the patient experienced joint pain in many joints that dissipated. The pain was dissipated in all joints within a week except in left elbow. The left elbow had exacerbated into tennis elbow. It was still hurting as of the end of March. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of join pain and tennis elbow were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: Chills through the night; fever; headache; pain in the left arm; body ache (back); This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247) via an unspecified route of administration in right arm on 30Mar2021 at 11:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included allergies. Concomitant medication received within two weeks of vaccination included Xyzal for allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 09Mar2021 at 10:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. On 31Mar2021 at 00:00, the patient experienced chills through the night, fever, headache, pain in the left arm and body ache (back). No therapeutic measure was taken for the events experienced. The event neither resulted in doctor or other healthcare professional office/clinic visit nor in emergency room/department or urgent care. The clinical outcome of the events chills through the night, fever, headache, pain in the left arm and body ache (back) was resolved with lasting effects.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation, Paraesthesia, Peripheral coldness
Clinical narrative: Immediate tingling (pins & needles)/ Over course of1 hour same symptom moved to add left hand, then right and left foot.; Physical coldness (very cold) inright hand (all fingers).; Physical coldness (very cold) inright hand (all fingers). Over course of1 hour same symptom moved to addleft hand, then right and left foot.; This is a spontaneous report from a contactable consumer, the patient. A 47-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA165969) via an unspecified route of administration in the left arm on 20Mar2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have allergies to medications, food, or other products. Concomitant medications included unspecified antihistamine (MANUFACTURER UNKNOWN), and WAL-PHED D (MANUFACTURER UNKNOWN); both for an unknown indication and from on an unknown date.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 15:00, the patient experienced immediate tingling (pins & needles) and physical coldness (very cold) in right hand (all fingers). Over course of 1-hour, the same symptom moved to "add" left hand, then right and left foot. (Right hand symptoms longest and most intense and felt very similar to cortisone shot given for carpal tunnel syndrome). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events included oxygen & pulse check (Pulse Oximetry test). The clinical outcomes of the event tingling (pins & needles), physical coldness (finger cold) in right hand (all fingers), cold feet and hands (very cold) were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort
Clinical narrative: Right ear clog can't hear feels like fluid; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number- UNKNOWN), via an unspecified route of administration in the right arm on 30Mar2021 at 10:00 (at the age of 57-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had history of allergy to penicillin. The patient did not receive any concomitant medication. Prior to vaccination the patient was diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 10:00, patient experienced right ear clog and reported that he could not hear and it felt like fluid. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ear clog can't hear felt like fluid were not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Massive headaches; very bad arm pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the arm right on 22Mar2021 at 13:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer and diagnosed COVID-19. The patient had no allergies to medications, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) and venlafaxine (MANUFACTURER UNKNOWN) taken for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 the patient experienced massive headaches and very bad arm pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of events massive headaches and very bad arm pain were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Nausea; Headache; Fever; This is a spontaneous report from contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) in the left arm on 29Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included high blood pressure and idiopathic intracranial hypertension (IIH). The patient had a known allergy to sulfur medication. The patient's concomitant medications included amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and fexofenadine hydrochloride (Allegra) all from unknown dates for an unknown indications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA, lot Number: EN 6204) in the left arm on 08Mar2021 at 08:15 (at the age of 43-years-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021, the patient experienced nausea, headache and fever. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of headache, fever and nausea. The clinical outcome of the events of nausea, headache and fever was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Confusional state, Dark circles under eyes, Dysgeusia, Gait disturbance
Clinical narrative: Body and Muscle cramps; Confused; Foul taste in mouth; Foul smell; Severe headache; Couldnt walk, Trouble walking; Black rings developed under eyes; Body burns; Fell asleep while talking; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Mar2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as yes, however medical history was unspecified. Concomitant medications were taken within two weeks of vaccination was reported; however, it was unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, at 06:00, the patient experienced body and muscle cramps, confusion, falling asleep while talking, foul taste in mouth, foul smell, unable to walk, severe headache, body burns, black rings developed under eyes, trouble walking. The patient had not received any treatment for the reported events. The clinical outcome of the events muscle cramps, confusion, taste peculiar, smell change, headache, difficulty in walking, dark circles under eyes, body temperature increased and sleepiness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Parosmia, Somnolence
Clinical narrative: Body and Muscle cramps; Confused; Foul taste in mouth; Foul smell; Severe headache; Couldnt walk, Trouble walking; Black rings developed under eyes; Body burns; Fell asleep while talking; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Mar2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as yes, however medical history was unspecified. Concomitant medications were taken within two weeks of vaccination was reported; however, it was unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, at 06:00, the patient experienced body and muscle cramps, confusion, falling asleep while talking, foul taste in mouth, foul smell, unable to walk, severe headache, body burns, black rings developed under eyes, trouble walking. The patient had not received any treatment for the reported events. The clinical outcome of the events muscle cramps, confusion, taste peculiar, smell change, headache, difficulty in walking, dark circles under eyes, body temperature increased and sleepiness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7534), via an unspecified route of administration on 22Mar2021 at 11:30 (at the age of 45-year-old), as a single dose for COVID-19 immunization. The patient had no medical history. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN) and B vitamin (MANUFACTURER UNKNOWN) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on the left arm on an unknown date, as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies. On 29Mar2021 at 08:00, the patient experienced feeling extremely fatigued and some muscle pain throughout the body. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue extreme and muscle pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: Red dots on both arms and legs.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737), via an unspecified route of administration in the right arm on 30Mar2021 at 17:00 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the right arm on 09Mar2021 at 14:00 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 07:00 (After 12 hours), the patient developed red dots on both arms and legs. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the red dots on both arms and legs. The clinical outcome of the event red dots on both arms and legs was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: SEVERE VERTIGO; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the arm left on 09Mar2021 at 12:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history was reported no. The patient did not receive concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6200) via an unspecified route of administration in the arm left on 16Feb2021 at 13:00 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior  the vaccination. The patient did not have Allergies to medications, food, or other product. On 15Mar2021 at 08:45 the patient was experienced severe vertigo. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of  severe vertigo was ongoing.    No follow-up attempts are needed. No further information is expected.